Title

Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia.

Document Type

Journal Article

Publication Date

8-1-2016

Journal

Leukemia research

Volume

47

Inclusive Pages

78-83

DOI

10.1016/j.leukres.2016.05.012

Keywords

Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Infection; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Thalidomide

Peer Reviewed

1

Find in your library

Share

COinS